Ordreindtastning
Denmark
Orders LinkContactUsLinkComponent
<i>E. coli</i> BL21

E. coli BL21

E. coli BL21, 1 Vial
Catalog # 27-1542-01
Supplier:   Cytiva
<i>E. coli</i> BL21
Catalog # 27-1542-01
Supplier:  Cytiva
CAS Number:  
<i>E. coli</i> BL21
E. coli BL21

E. coli BL21, 1 Vial

CAS Number:  
Price
2.590,00 kr
Log in for availability
1 * 1 Each
Product Details & Documents

The E. coli BL21 strain is protease-deficient for optimal expression of a variety of recombinant proteins.

  • High level expression of a variety of recombinant proteins
  • Defective in E. coli strain B and wild-type restriction systems to permit high efficiency transformation with unmodified plasmid DNA
  • Verified by RAPD fingerprint analysis using ready-to-go RAPD analysis kit
  • Supplied lyophilised

Well suited for use with the GST gene fusion system, E. coli BL21 is an exemplary host for the expression of recombinant proteins. As an E. coli B strain, it further lacks the major protease, encoded by the lon gene, catalysing the endoproteolytic cleavage of damaged and recombinant proteins in the cell.

The protease-minus nature of BL21 makes it useful as an expression host. Since BL21 does not transform well, use an alternate strain for cloning and maintenance of the vector.

Genotype: The BL21 strain is derived from E. coli B. The genotype is F-, ompT, hsdS (rB -, mB -), gal, dcm.

Growth conditions: Resuspend lyophilised cultures in 1 ml of LB medium. Grow overnight at 37 °C before plating onto LB agar plates.

Storage conditions: −20 °C. Mix equal volumes of stationary phase culture (grown in LB medium) and glycerol. Store at –70 °C. Revive frozen glycerol stocks of BL21 by streaking onto LB agar plates.

Specifications

Specifications

  • Pakn:
    1 Vial
  • Beskrivelse:
    <i>E. coli</i> BL21

Specifications

Recommendations

Recommendations will be personalized based on your shopping preferences only if you have given your consent by enabling "Enhance my Shopping Experience" on the "Personal Info page".

Otherwise, you will receive generic recommendations.